Kraj: Wielka Brytania
Język: angielski
Źródło: MHRA (Medicines & Healthcare Products Regulatory Agency)
Rabeprazole sodium
Zentiva Pharma UK Ltd
A02BC04
Rabeprazole sodium
10mg
Gastro-resistant tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 01030500; GTIN: 5000283655756
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT RABEPRAZOLE SODIUM 10MG GASTRO-RESISTANT TABLETS AND RABEPRAZOLE SODIUM 20MG GASTRO-RESISTANT TABLETS RABEPRAZOLE SODIUM READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Rabeprazole is and what it is used for 2. What you need to know before you take Rabeprazole 3. How to take Rabeprazole 4. Possible side effects 5. How to store Rabeprazole 6. Contents of the pack and other information 1. WHAT RABEPRAZOLE IS AND WHAT IT IS USED FOR The name of your medicine is Rabeprazole Sodium 10mg Gastro-resistant tablets or Rabeprazole Sodium 20mg Gastro-resistant tablets (called Rabeprazole throughout this leaflet). This belongs to a group of medicines called ‘proton pump inhibitors’ (PPIs). They work by lowering the amount of acid that your stomach produces. Rabeprazole is used to treat the following conditions: ‘Gastro-oesophageal reflux disease’ (GORD), which can include heartburn. GORD is caused when acid and food from your stomach escapes into your food pipe (oesophagus) Ulcers in your stomach or the upper part of your gut (intestine). If these are infected with bacteria called ‘_Helicobacter pylori_’ (_H. pylori_), you will also be given antibiotics. Using rabeprazole tablets and antibiotics together gets rid of the infection and makes the ulcer heal. It also stops the infection and ulcer from coming back Zollinger-Ellison syndrome where your stomach produces too much acid. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE RABEPRAZOLE DO NOT T Przeczytaj cały dokument
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Rabeprazole Sodium 10mg Gastro-resistant Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each gastro-resistant tablet contains 10 mg rabeprazole sodium (as anhydrate or monohydrate), equivalent to 9.42 mg rabeprazole For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Gastro-resistant tablet Rabeprazole Sodium 10 mg tablets: round, pink, film coated biconvex tablet with a diameter of about 5.5 mm. 4.1 THERAPEUTIC INDICATIONS Rabeprazole sodium gastro-resistant tablets are indicated for the treatment of: • Active duodenal ulcer • Active benign gastric ulcer • Symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GORD). • Gastro-Oesophageal Reflux Disease Long-term Management (GORD Maintenance) • Symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic GORD) • Zollinger-Ellison Syndrome • In combination with appropriate antibacterial therapeutic regimens for the eradication of _Helicobacter pylori_ in patients with peptic ulcer disease (see section 4.2). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults/Elderly people: _ ACTIVE DUODENAL ULCER AND ACTIVE BENIGN GASTRIC ULCER: The recommended oral dose for both active duodenal ulcer and active benign gastric ulcer is 20 mg to be taken once daily in the morning. Most patients with active duodenal ulcer heal within four weeks. However a few patients may require an additional four weeks of therapy to achieve healing. Most patients with active benign gastric ulcer heal within six weeks. However, again a few patients may require an additional six weeks of therapy to achieve healing. EROSIVE OR ULCERATIVE GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): The recommended oral dose for this condition is 20 mg to be taken once daily for four to eight weeks. GASTRO-OESOPHAGEAL REFLUX DISEASE LONG-TERM MANAGEMENT (GORD MAINTENANCE): For long-term management, a maintenance dose of rabeprazole sodium 20 mg or 10 mg once dai Przeczytaj cały dokument